The unintended consequences of clinical trials regulations
- PMID: 19918557
- PMCID: PMC2768793
- DOI: 10.1371/journal.pmed.1000131
The unintended consequences of clinical trials regulations
Abstract
Alex McMahon and colleagues critique the International Conference on Harmonisation (ICH) guidance on good clinical practice (GCP), arguing that it is having a disastrous effect on noncommerical randomized clinical trials in Europe.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Stewart PM, Stears A, Tomlinson JW, Brown MJ. Regulation – the real threat to clinical research. BMJ. 2008;337:1085–1087. - PubMed
-
- ICH Good Clinical Practice CPMP/ICH/135/95. 2002 Available: http://www.emea.europa.eu/pdfs/human/ich/013595en.pdf. Accessed 6 July 2009.
-
- Baum M, Buchanan M, Baselga J, Cataliotti L, Jassem J, et al. The future of breast cancer research in danger. Eur J Can. 2007;38:2210–2213. - PubMed
-
- Directive 2001/20/ EC of the European parliament and of the council of 4 April 2002 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Communities. 2001;L121:34–44. Available: http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/dir_2001_2.... Accessed 6 July 2009. - PubMed
-
- The Medicines for Human Use (Clinical Trials) Regulations 2004. 2004 Available: http://www.opsi.gov.uk/si/si2004/20041031.htm. Accessed 6 July 2009. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
